Quality is our legacy     
.
Site Language
.
.

.
 Search 
   Home
 
SEDICO Company
About SEDICO
News and Reports
Worldwide Presence
Careers at SEDICO
 
SEDICO products
Products List
Strategic Brands
Search for a product
 
Social Contribution
Diabetes Center
R&D
Caring for community
Access for medicines
 
Contact SEDICO
Contact Us
Distributors Log in
Partners Log in
Vendors Log in
Physicians Log in
Patients Log in
 
SEDICO Newsletter
Subscribe to SEDICO News

   Enter Your E-mail
 

Physician
Patient

Diagnosis and Management of Pulmonary Embolism
Current Concepts:
 
Blocking of the pulmonary artery by foreign matter such as a blood clot, fat, air, tumor tissue.
The third most common cause of death in hospitalized patients.
Most patients with DVT develop PE (Majority of cases are unrecognized clinically).
Untreated, approximately 1/3 of patients who survive an initial PE die of a future embolic episode.
 
Frequency:
In the US:
60% of patients who died in hospitals had PE.
The diagnosis was missed in up to 70%.
Prospective studies demonstrated DVT in:
10-13% of all medical patients placed on bed rest for 1 week,
29-33% of all patients in medical ICUs,
20-26% of patients with pulmonary diseases who stays at bed for ≥3 days,
27-33% of those admitted to a critical care unit after MI,
48% of patients who are asymptomatic after CABG.

 

Pathphysiology of PE:
VIRCHOW’S TRIAD
Local trauma to vessel wall
Hypercoagulability
Stasis
Hypercoagulable state
Inherited (Primary)
Secondary (Acquired)
Primary Hypercoagulable states
Acquired Hypercoagulable states
 
Non-imaging Diagnostic Methods:
PLASMA D-DIMER ELISA
•Natural Break down of fibrin to D-Dimers
•Sensitive but not specific as it
•Increases in MI, repsis, cancer, any other systemic
ABG
•No difference between average PaO2 in patients with and without PE
•Not part of diagnostic strategy
ECG
•Exclude AMI
•Raise suspicion of PE
•Confirm the diagnosis
 
Imaging Diagnostic Methods:
CXR
•Abnormal CXR in ¼ of patients.
•Focal oligemia (Westermark’s sign) indicates massive central embolic occlusion.
•Peripheral wedge shaped density above the diaphragm (Hampton’s hump) indicates pulmonary infarction.
•Small pleural effusion.
 
Spiral or the new multi-detector CT:
Replacing V/Q scan
Replacing pulmonary Angio in Dx
More specific, more accessible
Provides alternative diagnosis in 30% of cases
May miss sub segmental emboli
Give information about the size and function of RV
Requires a high dose of injected contrast (can use non iodinated contrast ) - check creatinine
Diagnostic even in the presence of an abnormal chest radiograph
 
Ventilation-Perfusion scan:
Perfusion scan:
•Technetium 99m-labeled macro aggregated albumin (MAA).
•injected intravenously.
Ventilation scan:
•Technetium 99m DTPA aerosol.
•Inhaled.

Second choice imaging test.
70% of patients have an indeterminate result and need another test to make the diagnosis.
Good in the presence of a normal chest radiograph.
Not helpful in the presence of an abnormal chest radiograph, in patients with COPD or cardiac disease.
Does not provide an alternative diagnosis.
 
Pulmonary angiography:
Was the Gold standard, replaced by the new multidetector CT scanning
Invasive - catheter inserted into femoral vein, up the IVC through into right-sided cardiac chambers and into pulmonary arteries.
Contrast injected directly into pulmonary arteries.
Required when interventions are planned as:-
•Suction catheter embolectmy.
•Mechanical clot fragmentation.
•Catheter directed thrombolysis.
 
With MRA:
Keep your tablets in the pack in which they were supplied.
Keep your tablets below 30°C.
Keep your tablets in a safe place where children cannot see or reach them.
Author Year # of pt  Techniques Sensitivity  Specificity
Meanly 1997  30 3D G 87%  97%
Gupta  1999  36 3D  Gd 85%  96%


 

Next


© 2004 Sedico Co. All rights reserved
Designed and Developed by EBM Co.